Condensed Statements of Consolidated Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Effect of Exchange Rate Changes on Cash	$ (288,000)	$ 4,099,000
Net income	178,301,000	85,513,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property	16,215,000	15,641,000
Amortization of intangibles	24,096,000	26,238,000
Impairment expense	0	49,528,000
Amortization of stock options and appreciation rights	2,897,000	1,930,000
Other share-based compensation expense	6,064,000	4,660,000
Changes in operating assets and liabilities, net of acquisitions	(106,136,000)	33,574,000
Other, net	12,386,000	(13,675,000)
Net Cash provided by Operating Activities	133,823,000	203,409,000
Cash Flows from Investing Activities
Acquisition of businesses, net of cash acquired	(6,974,000)	(30,023,000)
Capital expenditures	(11,674,000)	(12,177,000)
Proceeds from property sales	494,000	691,000
Life insurance proceeds	3,159,000	0
Cash payments for loans on company-owned life insurance	(14,835,000)	0
Net Cash used in Investing Activities	(29,830,000)	(41,509,000)
Cash Flows from Financing Activities
Net borrowings under revolving credit facility	442,592,000	0
Long-term debt repayments	550,432,000	82,070,000
Interest rate swap settlement payments	4,812,000	2,122,000
Payment of debt issuance costs	(1,956,000)	(399,000)
Purchases of treasury shares	(13,604,000)	0
Dividends paid	(38,612,000)	(37,772,000)
Acquisition holdback payments	2,361,000	2,344,000
Exercise of stock options and appreciation rights	224,000	163,000
Taxes paid for shares withheld for equity awards	(4,405,000)	(5,990,000)
Net Cash used in Financing Activities	(173,366,000)	(130,534,000)
(Decrease) increase in Cash and Cash Equivalents	(69,661,000)	35,465,000
Cash and Cash Equivalents at Beginning of Period	257,745,000	268,551,000
Cash and Cash Equivalents at End of Period	$ 188,084,000	$ 304,016,000